510(k) approval for General Surgical Innovations:
This article was originally published in Clinica
General Surgical Innovations' range of Spacemaker tissue dissection products has received 510(k) approval for its extended use which will include surgical use involving access to the spine and long-bone plating. Other applications are thoracoscopic procedures involving exposure and dissection of nerves, blood vessels and other tissues of the chest walls. The device produce surgical working space by separating natural tissue planes without the need to use blunt dissection as in conventional open surgery.
You may also be interested in...
The director of adult immunizations at Johns Hopkins International Vaccine Access Center talks to Scrip about undertaking a massive COVID-19 vaccination effort in the US.
P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.